Mark Takano (D-CA)

PrEP Access and Coverage Act of 2026

H.R. 7853 · House bill Health

A Democratic bill with 189 Democratic cosponsors · See all 189 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Government Reform, Ways and Means, Veterans' Affairs, Armed Services, Natural Resources, Financial Services, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The bill, known as the PrEP Access and Coverage Act of 2026, aims to increase access to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to reduce HIV transmission. It mandates that private health insurance, federal employee plans, Medicaid, CHIP, Medicare, Veterans Affairs healthcare, and TRICARE cover FDA-approved HIV prevention drugs and related services without cost-sharing or preauthorization in most cases. The legislation also prohibits life, disability, and long-term care insurance companies from denying coverage, raising premiums, or discriminating against individuals taking HIV prevention medication. Furthermore, it establishes public and provider education campaigns, grants for community health programs, patient confidentiality protections, and enforcement mechanisms to monitor compliance.

Yes· 3 of 45

  • Scored +10

    Would households on low incomes be better off under this?

    Provides zero-cost access via Medicaid, CHIP, and federal grants for the uninsured.

  • Scored +10

    Would LGBTQ people be better off under this?

    Focuses specifically on reducing HIV disparities and stigma for the LGBTQ community.

  • Scored +10

    Does this lower the price of prescription medicines?

    Eliminates out-of-pocket costs for FDA-approved HIV prevention drugs across multiple insurance types.

The opposite· 3 of 7

  • Scored -5

    Does this reduce what the federal government spends?

    Authorizes new appropriations for public education campaigns and grant programs.

  • Scored -3

    Would business owners be better off under this?

    Increases costs for employers providing group health insurance due to mandated coverage.

  • Scored -3

    Does this leave more decisions to the states?

    Reduces state flexibility in Medicaid/CHIP coverage for HIV prevention.